Cyclophosphamide

vascular endothelial growth factor A ; Mus musculus







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33840704 Gene expression analysis of fresh extraction wounds prior to onset of bisphosphonate-related osteonecrosis of the jaw-like lesions in mice: A preliminary animal study. 2021 Oct 15 1
2 28581681 Anti-vascular endothelial growth factor treatment decreases bladder pain in cyclophosphamide cystitis: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network animal model study. 2017 Oct 1
3 27515027 Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators. 2016 Aug 11 1
4 22589273 Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. 2012 May 15 1
5 19754361 Increased tumor oxygenation and drug uptake during anti-angiogenic weekly low dose cyclophosphamide enhances the anti-tumor effect of weekly tirapazamine. 2009 Sep 1
6 18632792 Upregulation of vascular endothelial growth factor isoform VEGF-164 and receptors (VEGFR-2, Npn-1, and Npn-2) in rats with cyclophosphamide-induced cystitis. 2008 Sep 2
7 16421623 Polysaccharides from the root of Angelica sinensis protect bone marrow and gastrointestinal tissues against the cytotoxicity of cyclophosphamide in mice. 2006 3
8 16699765 In vivo tumor angiogenesis imaging with site-specific labeled (99m)Tc-HYNIC-VEGF. 2006 Jul 1
9 16909595 [Combined low-dose chemotherapy inhibiting angiogenesis and growth of Lewis lung cancinoma xenografts in mice]. 2006 Jul 1